Optimvia, LLC
Cincinnati, OH · Founded 2016 · CIK 0001705874 · Biotech · Private
Engineered enzymes and cofactors for biosynthetic synthesis of complex therapeutic molecules, starting with heparin
optimvia.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $75K
- 4 Form D · Apr 2026
- 6 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 20
- 10 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,400,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $75,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1873 | COURAGE THERAPEUTICS INC | — | $4.5M |
| 1874 | Factor Holdings LLC | — | $25K |
| 1875 | TearSolutions, Inc. | — | $36M |
| 1876 | Optimvia, LLC | — | $75K |
| 1877 | Addex Therapeutics Ltd. | — | $14M |
| 1878 | STEMBIOSYS, INC. | — | $3.4M |
| 1879 | Prince Biotech, Inc. | — | $10M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Tarsis FerreiraDirector · Executive Officer · Promoter
- Steve GeisDirector
- John GlassDirector · Executive Officer · Promoter
- Keith KleemanDirector · Executive Officer · Promoter
- Mickey KowitzDirector
- James RothmanDirector
Patents
- Engineered Aryl Sulfate-dependent Enzymesapplication
- Engineered Aryl Sulfate-dependent Enzymesapplication
- Engineered Aryl Sulfate-dependent Enzymesapplication
- Methods For Synthesizing Anticoagulant Polysaccharidesapplication
- Engineered Aryl Sulfate-dependent Enzymesgranted
- Engineered Aryl Sulfate-dependent Enzymesgranted
- Engineered Aryl Sulfate-dependent Enzymesgranted
- Engineered Aryl Sulfate-dependent Enzymesgranted
- Engineered Aryl Sulfate-dependent Enzymesgranted
- Engineered Aryl Sulfate-dependent Enzymesapplication
- Methods For Synthesizing Anticoagulant Polysaccharidesgranted
- Engineered Aryl Sulfate-dependent Enzymesgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.